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   The overall objective of this thesis was to examine skeletal muscle function and 
the development of peripheral quadriceps fatigue in health and in patients with chronic 
obstructive pulmonary disease (COPD). The aim of the first study was to further 
elucidate the role of afferent feedback in the regulation of locomotor muscle fatigue 
during dynamic exercise by varying the amount of active muscle mass. Utilizing cycling 
(BIKE) and single-leg knee extensor (KE) exercise, far greater quadriceps fatigue at 
exhaustion was observed following KE exercise. These data imply that when the source 
of skeletal muscle afferent feedback is confined to a small muscle mass, the central 
nervous system tolerates a greater magnitude of peripheral fatigue, and likely a greater 
intramuscular metabolic disturbance; a finding that has important implications for the 
adoption of small muscle mass exercise in rehabilitative medicine. The second study 
sought to determine the impact of an acute oral antioxidant cocktail (AOC), with 
previously documented efficacy, on free radical concentration and KE exercise 
performance in patients with COPD. In this population, recognized to have elevated 
oxidative stress, administration of the AOC significantly attenuated resting free radical 
levels, which were negatively correlated with the degree of airflow limitation and 
baseline MVC force. Upon secondary analysis, however, a dichotomous response to the 
AOC was recognized, whereby the AOC appeared to be most efficacious in those patients 
with high initial free radical levels, with minimal effects when the initial free radical 
	   iv	  
load was low. Despite these antioxidant effects, no differences in KE exercise 
performance or the magnitude of peripheral quadriceps fatigue were evident following 
consumption of the AOC. These findings revealed that acutely reducing free radicals with 
an oral AOC does not translate to improved exercise capacity and fatigue resistance in 
patients with COPD. Collectively, this research has provided novel insight into the role of 
active muscle mass and the regulation of peripheral fatigue, and has better elucidated the 
link between free radicals, antioxidants, and fatigue in patients with COPD.  	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Defined as an acute impairment in performance, including an increase in the 
perceived effort to exert a desired force, and an eventual inability to produce this force 
(15), skeletal muscle fatigue directly limits exercise in both healthy and diseased 
populations (6, 17). Therefore, understanding the physiological and pathophysiological 
events governing the development of fatigue is important both scientifically and in the 
context of rehabilitative medicine. The processes contributing to a fatigue-induced 
decrease in muscle performance can be partitioned into central processes (proximal to the 
neuromuscular junction) and those arising at or distal to the neuromuscular junction 
(within the muscle cell) termed peripheral fatigue (35). As the relative contributions from 
primarily central or peripheral processes vary depending on, among other factors, the 
exercise task, length of the activity (15, 18), and environmental conditions (9, 27), the 
etiology of fatigue is often both complex and multifaceted. 
During short duration, high-intensity dynamic exercise, peripheral processes 
contribute significantly to muscular fatigue. Indeed, the accumulation of metabolic 
byproducts from skeletal muscle contraction (such as hydrogen ions and inorganic 
phosphates) depress the function of the cellular constituents of excitation-contraction 
coupling (ECC) (33). In addition, the production of reactive oxygen species (ROS) 
increases during fatiguing contractions, and these free radicals are similarly detrimental 
to ECC events (11, 34). The degree of intramuscular perturbation therefore plays a role in 
dictating the magnitude of peripheral muscle fatigue. In exercising humans, this can be 
assessed by a pre- to postexercise decline in the force evoked by supramaximal 
stimulation of the motor nerve innervating the active muscle group, reflective of changes 
that occurred within the muscle itself during exercise (3). 
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Interestingly, work by Amann et al. (5), experimentally altering the rate of 
development of peripheral fatigue by varying arterial oxygenation, has documented that 
despite improvements in fixed workload exercise time with increased arterial 
oxygenation (or reductions in performance time with arterial hypoxemia), the magnitude 
of peripheral quadriceps fatigue following dynamic, large muscle mass exercise was the 
same at task failure (~34% reduction in potentiated twitch force - ΔQpot,tw). In addition, 
following pre-fatiguing cycling bouts to induce a set level of quadriceps fatigue, central 
motor drive was modulated in subsequent 5 km cycle time trials, in a dose-dependent 
manner, such that participants again did not accumulate peripheral fatigue beyond the 
critical level (the ~34% ΔQpot,tw) (4). Accordingly, the authors postulated that central 
motor drive to the muscle is regulated by afferent feedback from the working skeletal 
muscle such that exercise cessation occurs at a sensory tolerance limit and a critical level 
of ensemble afferent input to the CNS to facilitate homeostasis (2). 
The interplay between the magnitude of peripheral locomotor muscle fatigue and 
afferent feedback from skeletal muscle has been demonstrated by experimentally 
blocking group III and IV thin-fiber afferents during dynamic exercise (6, 7). These 
skeletal muscle afferents, sensitive to mechanical deformation and the metabolic milieu 
of the muscle, are active during dynamic exercise (1) and contribute to the fine-tuning of 
the cardiovascular response (10). In regard to peripheral fatigue, blocking this source of 
afferent input to the CNS resulted in drastically elevated central motor drive to the 
muscle such that at the end of a 5 km cycle time trial the ~34% ΔQpot,tw was surpassed 
(~45% ΔQpot,tw) and serious atypical ambulatory difficulties were observed at task failure 
(7). These studies highlight the role of group III/IV afferents in the regulation of 
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peripheral fatigue; however, the link between the volume of exercise-induced ensemble 
afferent feedback and the degree of peripheral muscle fatigue during dynamic exercise 
has not been elucidated. 
Utilizing the postexercise circulatory occlusion technique to selectively stimulate 
metabolically sensitive afferents, Freund et al. (16) varied the mass of occluded muscle 
following dynamic cycle exercise. This study documented greater post-exercise mean 
arterial pressure (MAP) when two legs were occluded compared to just one, suggesting 
augmented afferent input to the CNS in proportion to the occluded muscle mass. As the 
sensory tolerance limit associated with exercise cessation appears to be substantially 
determined by the ensemble afferent signal from the working skeletal muscle (2), 
reducing the mass of active muscle mass could potentially lessen the signal during 
exercise. Thus, the sensory tolerance limit at task failure with dynamic, small muscle 
mass exercise would eventually be reached by a focused, but very strong, local afferent 
signal as opposed to the more diffuse signal (but of equal ensemble magnitude) achieved 
during whole body exercise. It is likely that the increased metabolic disturbance affecting 
less group III/IV afferents will take longer to reach the sensory tolerance limit, translating 
into a greater degree of contractile dysfunction at task failure. Accordingly, the first 
objective of this thesis was to determine the role of active muscle mass during dynamic 
exercise in the development of peripheral fatigue. 
Although the compromised pulmonary function intrinsic to lung disease certainly 
contributes to limited exercise capacity in chronic obstructive pulmonary disease (COPD) 
(8, 28), peripheral muscle abnormalities have also been implicated (23, 30). Specifically, 
structural abnormalities of skeletal muscle in COPD patients, such as a predominantly 
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type II skeletal muscle fiber phenotype (30), may hasten the production of metabolic 
byproducts intrinsic to the development of peripheral muscle fatigue (33). Indeed, 
significant peripheral locomotor muscle fatigue occurs in patients with COPD following 
cycle exercise (8, 24) and the perception of leg fatigue is frequently recognized as the 
primary symptom contributing to exercise intolerance in this population (20). In addition, 
the inflammatory pathology of lung disease increases the susceptibility of this group to 
oxidative stress (defined as an imbalance between pro- and antioxidant forces in favor of 
the former) (12, 13, 29, 32). Currently, the practical application of reducing the level of 
oxidative stress, and the impact on exercise tolerance, in patients with COPD has not 
been elucidated. 
Although free radicals directly impact the contractile apparatus (11, 34), their 
production has also been linked to an altered afferent signal. Specifically, ROS have been 
implicated in the exaggerated exercise pressor response typically observed in some 
disease states such as heart failure (21), and documented to increase the spontaneous 
firing of group IV afferents in resting and exercising mouse skeletal muscle (14). As the 
magnitude of afferent feedback plays an important role in determining exercise 
performance (2), oxidative stress may pathologically alter this signal. In COPD, 
antioxidant treatment has been documented to reduce markers of exercise-induced 
oxidant damage (19, 22), and the potent pharmacological antioxidant n-acetylcysteine 
(NAC) appears to improve exercise capacity (22). NAC, however, has also been 
documented to improve cycling time to exhaustion in healthy, young subjects (25, 26), 
and improve pulmonary function in patients with COPD (31), confounding interpretation 
of antioxidant administration on COPD patient skeletal muscle function. Thus, the second 
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aim of this thesis will be to examine the effect of a readily available, oral antioxidant 
cocktail with documented efficacy (29, 36, 37) on free radical concentration and the 
development of peripheral muscle fatigue in a population with a heightened susceptibility 
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Abstract 
 
The voluntary termination of exercise has been hypothesized to occur at a sensory 
tolerance limit that is significantly determined by feedback from group III and IV muscle 
afferents, and is associated with a specific level of peripheral quadriceps fatigue during 
whole body cycling. Therefore, the purpose of this study was to reduce the amount of 
muscle mass engaged during dynamic leg exercise to constrain the source of muscle 
afferent feedback to the central nervous system (CNS), and examine the effect on 
peripheral quadriceps fatigue. Eight young males performed exhaustive large (cycling – 
BIKE) and small (knee extensor – KE) muscle mass dynamic exercise at 85% of the 
modality-specific maximal workload. Pre- vs. postexercise maximal voluntary 
contractions (MVC) and supramaximal magnetic femoral nerve stimulation (Qtw,pot) were 
used to quantify peripheral quadriceps fatigue. Significant quadriceps fatigue was evident 
following both exercise trials; however, the exercise-induced changes in MVC (-28 ± 1% 
vs. -16 ± 2%) and Qtw,pot (-53 ± 2% vs. -34 ± 2%) were far greater following KE 
compared to BIKE exercise, respectively. The greater degree of quadriceps fatigue 
following KE exercise was in proportion to the greater exercise time (9.1 ± 0.4 vs. 6.3 ± 
0.5 minutes, p < 0.05), suggestive of a similar rate of peripheral fatigue development. 
These data suggest that when the source of skeletal muscle afferent feedback is confined 
to a small muscle mass, the CNS tolerates a greater magnitude of peripheral fatigue, and 
likely a greater intramuscular metabolic disturbance. An important implication of this 
finding is that the adoption of small muscle mass exercise may facilitate greater exercise-
induced muscular adaptation.  
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Introduction	  	   During high-intensity cycle exercise (BIKE), a centrally mediated sensory 
tolerance limit (25) associated with a set level of peripheral locomotor muscle fatigue has 
been documented (5, 9, 10, 13). This level of peripheral fatigue appears to be consistent 
across exercise bouts in which variations in arterial oxygenation alter the rate of 
development of peripheral fatigue and exercise time (13), but at the point of task failure, 
end-exercise locomotor muscle fatigue appears to be quite similar (10, 13, 14). In line 
with this observation, utilizing plantar flexion (28) or single leg knee-extension (52), 
which recruits a larger muscle mass, exercise and nuclear magnetic resonance 
spectroscopy, the metabolic disturbance at exhaustion has been documented to be 
invariant despite variations in arterial oxygenation, or work rate, altering exercise time to 
exhaustion. Therefore, it seems that it is possible to alter the rate of peripheral fatigue 
development and endurance time, but at exhaustion following short duration, high 
intensity exercise a similar intramuscular metabolic disturbance and level of peripheral 
locomotor muscle fatigue is achieved (9, 10, 13, 28, 52). 
Group III and IV muscle afferents are active during dynamic exercise (2, 6, 15) 
and provide input to the central nervous system (CNS) regarding mechanical deformation 
and the metabolic milieu within the working skeletal muscle (39, 48). Pharmacological 
blockade of these thin fiber afferents from the lower limbs during high intensity cycling 
exercise has highlighted the role of afferent feedback in limiting the development of 
peripheral fatigue (7, 12). Indeed, in the absence of group III/IV muscle afferents, 
subjects accumulated a significantly greater amount of peripheral fatigue such that 
atypical ambulatory difficulties were observed at exercise cessation (7, 12). The authors 
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of this work postulated that group III/IV afferent feedback from the working muscles 
modifies central motor drive to the locomotor muscle to ensure that the overall 
homeostasis of the organism is not threatened (5). Thus, the voluntary termination of 
exercise during high-intensity constant load endurance exercise occurs once a sensory 
tolerance limit (25) is reached that is substantially dependent, amongst other factors, on 
the ensemble afferent input from the active locomotor muscles (5, 9, 10, 12, 13). The 
corresponding level of peripheral fatigue presumably depends on the exercise task, and 
may vary with the amount of muscle mass recruited.  
A relationship between the magnitude of afferent feedback and muscle mass has 
long been established (22, 29). Freund et al. (22) demonstrated that post-bicycle exercise 
occlusion of blood flow to both legs maintained mean arterial pressure at a higher level 
than occlusion of one leg alone. In addition, time to task failure has been documented to 
be shorter, with less end-exercise quadriceps fatigue, for bilateral compared with 
unilateral sustained maximal voluntary contractions (MVC) of the knee extensor muscle 
group (37). In combination, these observations reveal that increasing active muscle mass 
augments the ensemble feedback to the CNS from the periphery and these changes in 
ensemble feedback may alter the level of end exercise fatigue and endurance time. 
However, the link between exercising muscle mass, the associated changes in afferent 
feedback and the degree of peripheral muscle fatigue following dynamic exercise has not 
been elucidated. 
Therefore, the purpose of this study was to reduce the amount of active muscle 
mass during dynamic exercise to confine group III/IV afferent feedback to one muscle 
group. Thus, the sensory tolerance limit associated with task failure and a critical amount 
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of ensemble afferent input, would eventually be reached by a strong local afferent signal 
from the isolated muscle group. This would contrast with the sum of the more diffuse 
weaker signals, with an equal ensemble magnitude, associated with whole body exercise 
(Figure 1). Specifically, we tested the hypothesis that exhaustive high intensity constant-
load dynamic knee extensor (KE) exercise, utilizing ~2.5 kg of muscle (17, 40), would 
result in a greater degree of end-exercise quadriceps fatigue compared to the equivalent 






Eight young, healthy males (24 ± 1 years, 83 ± 6 kg, 178 ± 4 cm) volunteered to 
participate in this study. Written, informed consent was obtained from participants prior 
to their inclusion and all protocols were approved by the Institutional Review Boards of 
the University of Utah and the Salt Lake City VA Medical Center. All testing was 
performed in a thermoneutral environment (22°C). 
  
Protocol 
Prior to data collection, subjects were familiarized with BIKE and KE exercise as 
well as the neuromuscular function assessment procedures during preliminary visits to 
the laboratory. On subsequent visits, separated by at least 48 hours, time to exhaustion 
(Tlim) during constant load exercise trials at 85% of maximal workload, for each exercise 
modality were used to induce quadriceps fatigue. This workload (85%) was selected 
because, during pilot testing, this intensity of effort elicited task failure in all subjects in 
~5 to ~12 minutes in both exercise modalities. Throughout each trial, ventilation, gas 
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exchange, heart rate (HR), and rating of perceived exertion (RPE) were assessed. Prior to 
each exercise bout, 2 minutes of resting data were collected and subjects were allowed a 
3-minute warm-up period (unloaded KE exercise and BIKE exercise at ~85 W). To 
quantify peripheral fatigue before exercise and 2 minutes following task failure, 
neuromuscular function tests were performed on the same leg used for both modalities. 
Task failure was defined as a drop of 10 rpm for both the KE and BIKE. The 
experimental limb was randomized and balanced between dominant and non-dominant 
legs (42).  
 
Bike (BIKE) and Knee-extensor (KE) Exercise 
Dynamic, small muscle mass exercise was performed on a cycle erogmeter 
(Monark, Sweden) modified to allow KE exercise (44). Briefly, this exercise modality 
recruits the quadriceps muscle group for active leg extension from 90 to ~170 degrees 
before a lever arm attached to a flywheel passively returns the leg to 90 degrees. Subjects 
were instructed to maintain a rate of 60 contractions per minute during KE exercise. For 
BIKE exercise, a cycle ergometer was employed (Excalibur, Lode, The Netherlands) and 
a constant pedaling rate was self-selected by all subjects (~75 rpm). For both exercise 
modalities, subjects performed one-minute stage, incremental exercise tests to exhaustion 
to determine peak workload (10 W + 5 W min-1 for KE and 20 W + 25 W min-1 for BIKE 
(16)).  
 
Ventilation, Gas Exchange and Heart Rate 
 
Ventilation and pulmonary gas exchange were measured at rest and during 
exercise with a metabolic cart (ParvoMedics, Sandy, UT). HR was determined from the 
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R-R interval of a three-lead electrocardiogram (ECG) acquired at 200 Hz using a data 
acquisition system (AcqKnowledge; Biopac Systems, Goleta, CA). RPE was taken every 




 The magnitude of peripheral quadriceps fatigue was quantified by supramaximal 
magnetic stimulation of the femoral nerve (9, 31, 43): the exercise induced reduction in 
potentiated quadriceps twitch force (Qtw,pot) assessed before exercise and again 2 minutes 
after both Tlim trials. This time delay was necessary to transfer the subjects from either 
exercise ergometer (BIKE or KE) to the neuromuscular function assessment apparatus, 
and was thus standardized for both exercise modalities. For the neuromuscular function 
test procedure, while subjects were semi-recumbent in a separate KE chair, with a knee 
joint angle of 90 degrees, a magnetic stimulator (Magstim 200, The Magstim Company 
Ltd, Wales) connected to a double 70 mm coil was used to stimulate the femoral nerve. 
The evoked twitch force was obtained from a calibrated load cell (Transducer 
Techniques, Temecula, CA) connected to a non-compliant strap placed around the 
subject’s ankle. To record magnetically evoked compound action potentials (M-waves) 
and evaluate changes in membrane excitability, quadriceps EMG was recorded from the 
vastus lateralis (VL) muscle (9). Electrodes were placed in a bipolar configuration over 
the middle of the muscle belly, with the active electrodes placed over the motor point of 
the muscle and reference electrode placed in an electrically neutral site. During a separate 
visit, supramaximality of stimulation was determined by serial, single unpotentiated 
twitch (Qtw) forces obtained every 30 seconds at 50, 60, 70, 80, 85, 90, 95, and 100% of 
maximal stimulator output.  
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 As potentiated, compared to unpotentiated, twitch force has been documented to 
be a more sensitive indicator of fatigue (31), Qtw,pot was assessed following a 5 second 
MVC of the quadriceps muscle. A series of 6 MVCs and Qtw,pot maneuvers were 
performed with 30 seconds between each MVC, such that the entire procedure lasted 2.5 
minutes. In addition, to quantify activation of the quadriceps during the MVCs, a 
superimposed twitch technique was employed (9, 38). Briefly, the additional force 
generated by a single twitch superimposed on the MVC was compared with the force 
produced by the potentiated twitch immediately following the MVC to determine the 
percent voluntary muscle activation (%VMA). Peak force, maximal rate of force 
development (MRFD), and maximal relaxation rate (MRR) were analyzed for all Qtw,pot 




Two-way repeated measures analysis of variance was used to compare the effect 
of exercise modality by time on the physiological parameters during exercise, with the 
Tukey’s honestly significant difference test used for posthoc analysis if a significant main 
or interaction effect was found. Student’s paired t tests were used to compare the effect of 
exercise modality on end-exercise physiological parameters and the magnitude of 
peripheral fatigue. Statistical significance was set at α = 0.05. Results are expressed as 














The maximal workload for the incremental exercise test was 280 ± 9 W for BIKE 
and 60 ± 4 W for KE exercise. Peak oxygen uptake was significantly higher for BIKE 
compared to KE exercise (3.2 ± 0.1 vs 1.6 ± 0.2 L/min). Tlim trial data are documented in 
Table 1. Cardiovascular and respiratory responses to the BIKE and KE TLim differed, 
with ventilation (VE), oxygen consumption (VO2), carbon dioxide production (VCO2), 
and HR all being higher during BIKE exercise (p < 0.05). Tlim time was longer, by 31 ± 
5% (range 46 seconds to 283 seconds), for KE compared to BIKE exercise (p < 0.05). 
RPE was lower for KE exercise at minutes 4 and 5 (p < 0.05), but was not different at 
exhaustion (Table 1).  
 
Neuromuscular Function  
A plateau in Qtw and M-wave amplitudes with increasing stimulus intensity 
documented maximal depolarization of the femoral nerve in all subjects. Membrane 
excitability was maintained from pre- to post-exercise in all trials, as indicated by 
unchanged M-wave characteristics, indicating that the observed changes in Qtw,pot were 
predominantly due to changes within the quadriceps. Qtw,pot measured after exercise was 
significantly reduced from pre-exercise values for both exercise modalities, with a fall of 
52 ± 2% for KE and 34 ± 2% for BIKE exercise, with no difference in the %VMA from 
pre- to post-exercise or between modalities. The fall in Qtw,pot  was significantly greater 
for KE compared to BIKE exercise, by 36 ± 4%, and in proportion to the greater exercise 
time. Other indices of fatigue (MVC, MRFD and MRR) were significantly reduced from 
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preexercise values, and also revealed greater peripheral fatigue following KE exercise 




The magnitude of group III/IV mediated afferent feedback from the active limbs 
substantially influences the voluntary termination of exercise, which has been suggested 
to occur once a sensory tolerance limit is reached (5, 25). By reducing the amount of 
active muscle mass during dynamic exercise, we sought to confine the source of afferent 
feedback to one muscle group in contrast to the ensemble feedback from many muscles 
during whole body exercise. Thus, a greater local metabolic disturbance at task failure 
with small muscle mass exercise would be required to elicit an afferent signal of equal 
magnitude to that achieved during whole body exercise (Figure 1). As the degree of 
metabolic disturbance significantly influences the magnitude of peripheral fatigue 
assessed immediately after exercise, it was hypothesized that small muscle mass exercise 
to exhaustion would result in a greater amount of peripheral fatigue than large muscle 
mass exercise. This was, indeed, the case, with KE exercise inducing significantly greater 
peripheral fatigue than BIKE exercise. These findings suggest that the CNS tolerates a 
greater degree of peripheral fatigue when the amount of active muscle mass is reduced. 
As exercise-induced peripheral adaptation responds to the degree of local perturbation, 
this study has implications for optimizing exercise training-induced muscle adaptations.  
 
Peripheral Fatigue and Large Muscle Mass (BIKE) Exercise 
 
 Previous work quantifying exercise-induced locomotor muscle fatigue following 
constant load, large muscle mass cycle exercise has identified a consistent level of 
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peripheral fatigue in a variety of populations (5). In a group of young, endurance trained 
individuals exercising at a high-intensity constant workload, Amann et al. (10) identified 
a ~34% decline in Qtw,pot from preexercise at exhaustion; altering arterial oxygenation 
affected endurance time, but not the observed threshold level of peripheral fatigue (10). 
In older, sedentary individuals, work by Mador et al. (33) documented a similar ~36% 
fall in Qtw,pot following exhaustive constant-load cycling. Interestingly, even moderate to 
severe chronic obstructive pulmonary disease patients have been documented to exhibit a 
~35% decline in potentiated twitch force following cycle exercise (34, 49). 
In the current study, BIKE exercise to exhaustion elicited quadriceps fatigue in all 
subjects, as exemplified by a consistent pre- to postexercise decline in MVC force (16%) 
as well as a 34% decline in Qtw,pot (Figure 3). Our intra-twitch indices, MRFD and MRR, 
which reflect reductions in the rate of calcium reuptake by the sarcoplasmic reticulum as 
well as cross-bridge dissociation (50), were similarly attenuated (~30% and ~33%, 
respectively). Of note, the mean decline in Qtw,pot was in agreement with values observed 
in the aforementioned studies. These similarities suggest that although factors such as 
oxygen availability, fitness level, age, and disease state influence the rate of development 
of peripheral fatigue, an apparently similar level of peripheral fatigue coincides with task 
failure during large muscle mass exercise.  
 
Peripheral Fatigue and Small Muscle Mass (KE) Exercise  
 
The knee extensor ergometer model provides a paradigm in which dynamic 
exercise can be limited to the quadriceps muscles (44). During KE exercise, Vanhatalo et 
al. (52) has documented a similar increase in inorganic phosphates and ADP, and fall in 
phosphocreatine and intramuscular pH assessed by nuclear magnetic resonance 
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spectroscopy, at task failure across work rates in both normoxia and hyperoxia. In 
addition, Fulco et al. (23) documented an equivalent fall in MVC force following 
exhaustive KE exercise in both hypobaria and normoxia. Utilizing evoked, potentiated 
twitch forces, Burnley et al. (20) documented a ~52% decline in Qtw,pot with electrical 
femoral nerve stimulation following exhaustive intermittent isometric contractions of the 
quadriceps, and Polkey et al. (43) found an equivalent reduction (~55%), following a 
similar exercise bout, with magnetic stimulation of the femoral nerve.  
In the current study, the quantification of exercise-induced quadriceps fatigue 
revealed a 53% reduction in Qtw,pot and ~28% fall in MVC force following KE exercise, 
whereas MRFD and MRR were reduced by ~53 and 46%, respectively (Figure 3). 
Interestingly, the magnitude of the exercise-induced decrease in the evoked twitch force 
in this study (~53%) was very similar to the values observed in previous work (~52% and 
55%) utilizing the Qtw,pot maneuver following quadriceps exercise to task failure (20, 43). 
Taken together, these studies, and our results, are suggestive of a similar level of end 
exercise peripheral quadriceps fatigue following small muscle mass exercise to task 
failure. Interestingly, the magnitude of peripheral fatigue when the exercise is confined to 
a small muscle mass may be greater then that obtained at exhaustion with whole body 
exercise.  
 
Muscle Mass, Afferent Feedback and Fatigue 
 
This study sought to compare the magnitude of peripheral fatigue following the 
voluntary termination of KE and BIKE exercise. Despite the matching of exercise 
intensity (85% of peak workload), KE exercise time was longer, by ~31%, and the 
magnitude of peripheral fatigue assessed following task failure was ~36% greater in 
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comparison to BIKE exercise. The proportionality between the increased time to fatigue 
and magnitude of fatigue, although speculative, suggests a similar rate of peripheral 
fatigue development, with the ability to achieve a greater degree of end-exercise 
peripheral fatigue potentially contributing to the greater exercise time. These results 
imply that at any given time point, achieved in both BIKE and KE trials, the magnitude 
of peripheral quadriceps fatigue was equivalent for both exercise modalities. During KE 
exercise with a reduced active muscle mass limiting the source of muscle afferent signal 
to the quadriceps, a similar magnitude of peripheral fatigue was likely associated with 
decreased ensemble input to the CNS. Indeed, during BIKE exercise, peripheral fatigue 
in both legs substantially augmented afferent feedback. Thus, subjects continued to drive 
the quadriceps muscle and delve deeper into its functional capacity during KE exercise, 
eventually reaching a greater level of quadriceps fatigue and presumably end-exercise 
metabolic disturbance, ultimately eliciting a muscle afferent signal of equal ensemble 
magnitude to that obtained with whole body BIKE exercise at task failure.  
A greater magnitude of peripheral fatigue was evident in all measured indices 
following KE exercise (Figure 2). With this reduction in active muscle mass, subjects 
surpassed the  ~34% decline in Qtw,pot observed following BIKE exercise, and continued 
until quadriceps contractile function was reduced by ~53%. This difference was also 
reflected in all other indicators of peripheral fatigue with an approximate two-fold greater 
decrease in MVC force, despite equal %VMA and therefore similar levels of central 
fatigue, and attenuated intra-twitch indices (Figure 2) following KE exercise. It is likely 
that when the source of afferent feedback to the CNS is constrained to the ~2.5 kg of 
muscle engaged during KE exercise, in contrast to the sum of multiple, more diffuse, 
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inputs from the ~15 kg of muscle utilized during BIKE exercise, the CNS tolerates a 
greater local accumulation of metabolic byproducts in the quadriceps, which impact 
peripheral fatigue (3, 4, 54). Thus, the sensory tolerance limit associated with exercise 
cessation and significantly influenced by, amongst other factors, the magnitude of 
ensemble afferent feedback, was likely reached with a greater degree of local skeletal 
muscle homeostatic disturbance during small muscle mass exercise (Figure 1). 
 
Active Muscle Mass and the Potential for Adaptation  
 
The utility of reducing active muscle mass during endurance training bouts to 
enhance peripheral muscle adaptation has been previously documented (1, 35, 46). 
Magnussen et al. (35) trained one set of quadriceps at a time with dynamic KE exercise 
and elicited large peripheral skeletal muscle adaptations (increased oxidative enzyme 
activity and capillarity) in chronic heart failure patients. Richardson et al. (46) 
documented a ~35% increase in quadriceps VO2peak in young, healthy subjects 
following an 8 week KE training program, which outstrips the typical 6-20% gains 
following whole body training. In addition, Abbiss et al. (1) documented increased 
cytochrome c oxidase subunits II and IV following single leg, compared with double leg, 
cycle training. As exercise training induces an adaptive response to a homeostatic 
disturbance, a greater degree of peripheral fatigue during small muscle mass exercise 
may provide a greater impetus for skeletal muscle adaptation. Thus, when the active 
muscle mass is kept small during dynamic exercise, an enhanced adaptation in response 
to a greater homeostatic disturbance may therefore be possible. In essence, the adoption 
of such a small muscle mass approach to exercise training could mean that the sum of the 
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parts will be greater than the whole, which has significant implications for exercise 
training in both healthy and diseased populations.  
 
Experimental Considerations  
 
 It is important to acknowledge that dissimilarities in the cardiovascular and 
respiratory responses to KE and BIKE exercise were evident, which could raise concerns 
about the role of oxygen supply and utilization (Table 1). However, experimental 
manipulations of oxygen availability achieved by altering arterial oxygen content (8) 
during exercise performance tests have been proposed to act via oxygen delivery to the 
working muscle and not the end-exercise level of peripheral fatigue (8). In addition, 
although fatiguing respiratory muscle work may increase afferent activity (27), the 
alleviation of diaphragm fatigue with proportional assist ventilation does not alter the 
end-exercise level of peripheral fatigue during BIKE exercise (11). Therefore, in the 
current study, as in previous work (5, 24), peripheral fatigue likely played a significant, 
autonomous role in curtailing exercise performance. 
Additionally, although our conceptual schematic (Figure 1) paints a uniform 
picture of increased afferent feedback with increasing muscle recruitment, we 
acknowledge that the characteristics of group III/IV afferents are more complicated. 
Certainly, some pathophysiological conditions are associated with alterations in group 
III/IV afferent sensitivity or their elicited reflexes (41). In addition, the role of these 
fibers can vary across skeletal muscle fiber type and muscle group (29, 36), and thus the 
picture is not actually so simple. Indeed, the increase in afferent feedback achieved by the 
increase in active muscle mass in our study from KE to BIKE was likely not directly 
proportional to the change in muscle mass. However, BIKE exercise included the 
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addition of the contralateral quadriceps performing the same action (knee extension from 
~90 to ~180 degrees), with added afferent feedback from other active muscles, which, 
although of unknown magnitude, would probably have greatly exaggerated the difference 
in ensemble afferent feedback. 
 Alternative explanations for the differences in peripheral fatigue following BIKE 
and KE exercise are also possible. Task specificity is an important facet in the etiology of 
fatigue (18) and although BIKE and KE exercise are similar, differences in neural 
activation strategies could have affected our results. Of importance, the relative 
contributions of peripheral and central fatigue could have varied between the two 
modalities. Although we attempted to measure central fatigue by the superimposed twitch 
technique and %VMA, and even though we did not observe any differences from pre- to 
post-exercise, or between BIKE and KE exercise, the time delay (2 minutes) between 
task failure and our fatigue measurements was probably too great to validly detect central 
fatigue. In addition, this time delay potentially could have led to an underestimation of 
the degree of peripheral fatigue at the moment of task failure, due to the extremely fast 
kinetics of phosphocreatine recovery. However, this time delay was logistically 
unavoidable to standardize the fatigue assessment protocol for both KE and BIKE 
exercise, so these effects, if present, were presumably constant between both trials.  
The ability of the magnetic stimulation technique to achieve supramaximility of 
stimulation following exercise is another potential concern. Specifically, varying degrees 
of activity-dependent hyperpolarization (51) of the quadriceps motor neurons following 
exercise may have led to a change in motor unit recruitment elicited by the supramaximal 
stimulation intensity prior to exercise. However, a recent comparison by Verges et al. 
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(53) of the magnetic stimulation technique with electrical stimulation revealed no 
difference between techniques in the magnitude of measured fatigue following exercise.  
Thus, these data contend that the twitch data does, in fact, represent changes within the 
quadriceps muscle, but a change in axon excitability, and thus axon recruitment following 
exercise can not be completely ruled out.  
Finally, the conclusions drawn from the current study are largely based on the 
assumption that afferent feedback was different between exercise modalities and in 
proportion to the metabolic disturbance in the quadriceps, neither of which were directly 
measured. Indeed, this study would have benefited greatly from a valid and feasible 
technique for the measurement of group III/IV afferent activity during dynamic exercise 
in humans, but currently this does not exist. Our group has previously utilized a partial 
afferent block to demonstrate the obligatory role of these afferents in the cardiovascular 
and respiratory response to both BIKE (6) and KE (15) exercise, but in the current study, 
it was not deemed that this approach  would actually have better elucidated the role of 
afferent feedback. In regard to differences in the end exercise metabolic disturbance, we 
have previously documented intramuscular pH values following KE exercise of ~6.5 
(45), a value considerably lower than that typically reported following maximal BIKE 
exercise (30). Therefore, in the context of previous research, and not without limitations, 
it can be contended that afferent feedback was varied, which enabled subjects to 




Confining group III/IV afferent feedback to a small muscle mass during dynamic 
KE exercise, in contrast to the multiple sources during whole body cycling, resulted in a 
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greater degree of peripheral fatigue following constant load exercise to exhaustion. This 
finding further highlights the role of afferent feedback in limiting the development of 
peripheral fatigue. Additionally, this study reveals that much greater local skeletal muscle 
fatigue can be achieved by utilizing small muscle mass exercise and thus may promote 
enhanced exercise-induced adaptation, with implications for the application of exercise 
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Table 1. Physiological responses to constant workload trials at exhaustion during 





BIKE (85%  
of peak workload) 
KE (85% 
of peak workload) 
Time to Exhaustion (s) 378 ± 30 547 ± 22.7* 
Workload (W) 238 ± 8 52 ± 4* 
Oxygen Consumption (L/min) 3.1 ± 0.1 1.8 ± 0.2* 
Carbon Dioxide Production (L/min) 3.4 ± 0.2 2 ± 0.2* 
Ventilation (L/min) 116 ± 9 84 ± 6* 
VE/VCO2 34.9 ± 1.9 42.6 ± 0.9* 
Heart Rate (bpm) 166 ± 4 130 ± 5* 
RPE 10 ± 0 10 ± 0 
Values expressed as mean ± S.E.M. VE/VCO2, ventilation relative to carbon dioxide 
production. RPE, rating of perceived exertion. *Significant difference between KE and 



































Figure 1. Conceptual schematic illustrating the equal magnitude of ensemble group 
III/IV skeletal muscle afferent feedback at task failure in both large (cycling - BIKE) and 
small (knee extensor - KE) muscle mass exercise. Group III/IV afferent feedback from 
active skeletal muscle is represented by the grey area. Accordingly, the sensory tolerance 
limit (10) influenced by the magnitude of ensemble afferent feedback and obtained by the 
sum of many diffuse signals during BIKE exercise (thin arrows; 1X10 = 10) (A) is 
reached with a focused, but very strong, local signal elicited by a greater intramuscular 
metabolic disturbance in the quadriceps (thick arrows; 5X2 = 10) at task failure during 
knee extensor exercise (B). 
 
 





Figure 2. Change in quadriceps muscle function following constant load large (cycle -
BIKE) and small (knee extensor - KE) exercise to exhaustion. Data are represented as 
mean ± S.E.M. and values represent the percent change from pre- to post-exercise. MVC, 
maximal voluntary contraction; Qtw,pot, potentiated twitch force; MRFD, maximal rate of 
force development; and, MRR, maximal rate of relaxation. *Significant difference 
between KE and BIKE exercise.  
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Abstract 
 
Oxidative stress may contribute to reduced exercise tolerance in patients with 
chronic obstructive pulmonary disease (COPD). This study sought to determine the effect 
of an oral antioxidant cocktail (AOC: vitamins C, E, and alpha-lipoic acid), with 
documented efficacy, on skeletal muscle function in COPD patients during dynamic 
quadriceps exercise. Ten patients with COPD (FEV1/FVC < 0.7, FEV1 ≤ 80% predicted) 
performed knee extensor (KE) exercise to exhaustion and trials matched for time 
(isotime) following consumption of either the AOC or placebo (PL). Maximal voluntary 
contractions (MVCs) and supramaximal magnetic femoral nerve stimulation (Qtw,pot) 
quantified the degree of peripheral quadriceps fatigue. Despite increasing plasma 
ascorbic acid levels (10.1 ± 2.2 to 24.1 ± 3.8 ug/ml, p < 0.05) and reducing the electron 
paramagnetic resonance (EPR) spectroscopy signal (AUC: 11.6 ± 3.7 to 4.8 ± 2.2 AU, p 
< 0.05) prior to exercise, AOC consumption did not alter endurance time or the 
magnitude of quadriceps fatigue. Closer examination of the EPR spectroscopy data 
revealed a tendency for the AOC to be most efficacious in patients with high resting free 
radical levels (n = 5, AUC: 19.7 ± 5.8 to 5.8 ± 4.5 AU, p < 0.05) compared to those with 
lower values (n = 4, AUC: 1.6 ± 0.5 to 3.4 ± 1.1 AU). Interestingly, this baseline index of 
free radicals was inversely correlated with FEV1 (r = -0.54, p = 0.08) and baseline MVC 
force (r = -0.56, p = 0.09). Together, although it appears that the heterogeneity of free 
radical load in patients with COPD might have played a role, these findings reveal that 
acutely reducing free radicals with an oral AOC does not translate to improved exercise 






Oxidative stress, defined as an imbalance between pro- and antioxidant forces in 
favor of the former (45), is prevalent in patients with chronic obstructive pulmonary 
disease (COPD) (15, 17). Although numerous factors contribute to the elevated oxidant 
burden documented in these patients, the most accepted source of free radicals is the 
inflammatory pathology of the lung disease itself (50). However, following exhaustive 
knee extensor (KE) exercise, which minimally taxes the lungs (47), elevations in markers 
of oxidative damage, such as plasma lipid peroxidation products (LPP) and stimulated 
phagocyte superoxide (O2-) production, have been recognized to increase in patients with 
COPD, but not healthy controls (15). Additionally, inhibiting the O2- generator xanthine 
oxidase in these patients ameliorated the exercise induced increase in LPPs and prevented 
an increase in the oxidized to reduced glutathione ratio (GSSG:GSH) (22). Collectively, 
these studies implicate exercising skeletal muscle as a significant source of free radicals, 
contributing to the oxidant burden in this population. 
  Although the impaired pulmonary function that is intrinsic to lung disease 
certainly contributes to limited exercise capacity in COPD (6, 39), peripheral muscle 
abnormalities have also been implicated (29, 46). Indeed, significant peripheral 
locomotor muscle fatigue occurs in patients with COPD following cycle exercise (6, 31) 
and the perception of leg fatigue is frequently recognized as the primary symptom 
contributing to exercise intolerance (23). A failure to improve pulmonary function with 
treatment is a hallmark of the disease, thus enhancing quality of life and exercise capacity 
primarily through peripheral muscle therapy is regarded as an important rehabilitative 
tool (20, 32). As free radicals both depress muscle force production (7) and exaggerate 
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the discharge from thin-fiber muscle afferents (19, 26), which are inherent in the 
regulation of peripheral muscle fatigue (3-5), targeting oxidative stress in COPD to 
directly attenuate muscle fatigue and improve exercise tolerance appears to be a real 
possibility.  
Pretreatment with the potent pharmacological antioxidant N-acetylcysteine 
(NAC), a GSH precursor, has been documented to improve quadriceps exercise 
endurance and lessen markers of oxidative damage at exhaustion in patients with COPD 
(27). However, NAC also appears to improve both small muscle mass (44) and whole 
body (33, 34) exercise tolerance in young, healthy individuals, suggesting its benefits 
may not be unique to a cohort with a heightened susceptibility to oxidative stress. In 
addition, NAC has been documented to improve pulmonary function during exercise in 
patients with COPD (48), further confounding the interpretation of the apparent benefit to 
peripheral muscle function in this population. Adverse side effects of NAC, such as 
lightheadedness and nausea (44), also potentially limit the efficacy of this antioxidant as a 
therapeutic intervention. There is currently little known about the potential of other 
antioxidant interventions to improve exercise tolerance in patients with COPD.  
 Therefore, we sought to examine the effects of an orally administered, readily 
available, antioxidant cocktail (AOC; vitamin C, vitamin E, and α-lipoic acid) with 
demonstrated efficacy (45, 53, 54), on free radical concentration and skeletal muscle 
fatigue following dynamic KE exercise in patients with COPD. Specifically, we tested 
the hypotheses that in patients with COPD, the AOC would: 1) raise antioxidant levels 
and decrease free radicals, as assessed by plasma ascorbate concentration and electron 
paramagnetic resonance (EPR) spectroscopy, 2) improve exercise capacity, as measured 
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by constant load KE exercise time to exhaustion, and 3) attenuate the development of 
peripheral quadriceps fatigue, quantified by magnetic stimulation of the femoral nerve, 







Eleven patients with COPD were recruited for this study based on spirometric 
evidence of moderate to severe airflow obstruction (FEV1 < 80% predicted, FEV1 / FVC 
≤ 0.7 (14)), as assessed by standard pulmonary function tests (36). Written, informed 
consent was obtained from participants prior to their inclusion and the Institutional 
Review Boards of the University of Utah and the Salt Lake City VA Medical Center 




Prior to data collection, all subjects were thoroughly familiarized with KE 
exercise, constant load exercise trials to exhaustion (TLim), as well as the neuromuscular 
function assessment. Peak KE work rate was determined with subject specific protocols 
designed to elicit maximum effort within 8-12 minutes, consisting of a 2-5 Watt/min 
increases at a cadence of 60 rpm. On subsequent visits, two Tlim trials separated by at 
least 48 hours, at 80% of maximal workload were performed following ingestion of either 
the AOC or PL in a counterbalanced order. The shorter of the two TLim times was then 
matched with the opposite condition (AOC or PL) on a successive visit to allow isotime 
comparisons. Throughout all trials, ventilation, gas exchange, heart rate, ratings of 
perceived exertion and breathlessness, arterial oxygen saturation, femoral blood velocity 
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and quadriceps electromyograms (EMG) were measured. Prior to each exercise bout, one 
minute of resting data were collected and subjects performed one minute of unloaded 
warm-up KE exercise. To quantify peripheral fatigue, neuromuscular function tests were 
performed before exercise and 10 minutes after task failure (<50 rpm). Venous blood 
samples were taken prior to and 1 hour after ingestion of the second dose of PL or AOC 
and immediately after KE exercise, to determine pro- and antioxidant status, and for spin 
trapping and EPR spectroscopy to directly assess free radical concentration. 
 
Oxidative Stress, Antioxidant Assays, and Free Radicals 
 
Plasma samples were stored at -80°C until analysis. Lipid peroxidation, a marker 
of oxidant damage, was assessed by thiobarbituric acid reactive substances (TBARS) and 
malondialdehyde levels (55) (Bioassays Systems, Hayward, CA).  Total antioxidant 
capacity was assessed by determining the ferric reducing ability of plasma (FRAP), using 
the method described by Benzie and Strain (11). Although the efficacy of the AOC 
specific to plasma ascorbate levels was also assayed, as previously described (13) 
(CosmoBio, Carlsbad, CA). Endogenous antioxidant activity, assessed by superoxide 
dismutase (SOD) and catalase (CAT) activity, was also assayed in the plasma (51) 
(Cayman Chemical Company, Ann Arbor, MI). 
 To directly assess the ability of the AOC to reduce the concentration of free 
radicals, EPR spectroscopy was performed on pre- and postexercise blood samples, as 
previously described (45). Briefly, 3 ml of venous blood was collected into a vacutainer 
containing 1 ml of the spin trap α-phenyl-tert-butylnitrone (PBN) (0.0140 mol/l). After 
centrifugation, the PBN adduct (200 µl) was pipetted into a precision-bore quartz EPR 
sample tube (Wilmad, Vineland, NJ). EPR spectroscopy was then performed at 21°C 
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using an EMX X-band spectrometer (Bruker, MA) and commercially available software 
(version 2.11, Bruker Win EPR System), which was also used to calculate the AUC of 
the EPR spectroscopy signal by double integration.  
 
Ventilation, Gas Exchange, Heart Rate, and Perceived Exertion 
 
Ventilation and pulmonary gas exchange were measured at rest and during 
exercise with a metabolic cart (ParvoMedics, Sandy, UT). Heart rate, determined from 
the R-R interval of a three-lead electrocardiogram (ECG), and arterial oxygen saturation 
(SaO2), estimated using a pulse oximeter (Nellcor N-595, Pleasanton, CA, USA) with 
adhesive forehead sensors, were acquired at 200 Hz using a data acquisition system 
(AcqKnowledge; Biopac Systems, Goleta, CA). Ratings of perceived exertion (RPE) 
were taken every minute during the exercise trials using Borg’s modified CR10 scale 
(12).  
 
Leg Blood Flow Assessment 
 
Measurements of femoral artery blood velocity and vessel diameter in the leg 
being studied were performed at rest and throughout exercise, using a Logic 7 ultrasound 
system (General Electric Medical Systems, Milwaukee, WI, USA) as previously 
described (49). Briefly, arterial diameter was measured, and mean velocity (Vmean) values 
(angle-corrected, and intensity weighted area-under-the-curve) were calculated using 
commercially available software (Logic 7). Using arterial diameter and Vmean, blood flow 







Quadriceps electromyograms (EMG) were recorded from the vastus lateralis (VL) 
muscle (2). Electrodes were placed in a bipolar configuration over the middle of the 
muscle belly, with the active electrodes placed over the motor point of the muscle and the 
reference electrode in an electrically neutral site over the tibial tuberosity. These 
electrodes were used to record magnetically evoked compound action potentials (M-
waves) to evaluate changes in membrane excitability, as well as EMG from the VL 
throughout exercise to provide an index of central motor drive. Raw EMG signals were 
filtered with a bandpass filter (with a low pass cut-off frequency of 15 Hz and a high pass 
cut-off frequency of 650 Hz) and after visual inspection of the filtered signal, a threshold 
voltage was set to identify the onset of EMG activity (AcqKnowledge; Biopac Systems, 
Goleta, CA). For data analysis, the integral of each EMG burst (integrated EMG, iEMG) 
was calculated to determine a percent increase in iEMG from the first minute of exercise 
(2).  
The magnitude of peripheral quadriceps fatigue was quantified by supramaximal 
magnetic stimulation of the femoral nerve (2, 28, 42). Specifically, Qtw,pot was assessed 
before and after each exercise trial. For this procedure, while subjects lay semi recumbent 
in a KE chair, with a knee joint angle of 90 degrees, a magnetic stimulator (Magstim 200, 
The Magstim Company Ltd, Wales UK) connected to a double 70 mm coil was used to 
stimulate the femoral nerve. The evoked twitch force was obtained from a calibrated load 
cell (Transducer Techniques, Temecula, CA) connected to a non-compliant strap placed 
around the subject’s ankle and acquired at 200 Hz with a data acquisition system 
(AcqKnowledge; Biopac Systems, Goleta, CA). Supramaximality of stimulation was 
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determined by serial, single unpotentiated twitch (Qtw) forces obtained every 30 seconds 
at 70, 80, 85, 90, 95, and 100% of maximal stimulator output on a separate visit to the 
laboratory.  
A series of six MVCs and Qtw,pot maneuvers were performed with 30 seconds 
between each MVC. In addition, to quantify activation of the quadriceps during the 
MVCs, a superimposed twitch technique was employed (2, 35). Briefly, the additional 
force generated by a single twitch superimposed on the MVC was compared with the 
force produced by the potentiated twitch immediately following the MVC to determine 
the percent voluntary muscle activation (%VMA). Peak force, maximal rate of force 





Two-way repeated measures ANOVA was used to compare the effect of 
antioxidant treatment on physiological parameters during exercise, with a Tukey posthoc 
analysis if a significant main effect were found. Student’s paired t tests were used to 
compare the effect of the AOC in terms of antioxidant efficacy, end exercise 
physiological parameters, and indices of peripheral fatigue. Correlations between 
variables were evaluated using Pearson correlation coefficients. Statistical significance 
was set at α = 0.05 for all tests. All group data are expressed as means ± standard error of 










Eleven subjects took part in the initial stages of the study, whose data are 
reflected in Table 2. However, complete muscle function and exercise data are presented 
only for the 10 subjects who completed the entire study, with the exception of blood 
sample data from one individual. Interestingly, resting free radical concentration, 
assessed by EPR spectroscopy, was inversely correlated with FEV1 and baseline MVC 




Consumption of the AOC increased plasma ascorbic acid levels and reduced the 
EPR spectroscopy signal AUC (Figure 4), but did not alter any other markers of oxidative 
stress (TBARS: 5.1 ± 0.3 vs 4.7 ± 0.3 uM, MDA: 1.2 ± 0.1 vs 1.1 ± 0.1 uM) or 
antioxidant status (FRAP: 0.99 ± 0.1 vs 1.0 ± 0.1 SOD: 21.4 ± 5.5 vs 20.5 ± 5.3 U/ml, 
catalase: 22.4 ± 2.8 vs 27.7 ± 5.0 nmol/min/ml, PL vs AOC respectively) prior to 
exercise. Following exercise, FRAP was increased above the PL condition with the AOC 
(1.0 ± 0.1 vs 1.1 ± 0.1 mM, p<0.05, respectively), however, there were no other 
significant pre- to post-exercise changes.  
 
Performance Trials  
 
Exercise to exhaustion resulted in a decrease in quadriceps muscle function, as 
illustrated by reductions in all measured indices of fatigue (MVC, Qtw,pot, MRFD, and 
MRR) and an increase in the iEMG signal. M-wave characteristics were maintained from 
pre- to postexercise, indicating preserved membrane excitability. In addition, the %VMA 
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was reduced by ~5% following both exercise trials. AOC consumption, however, did not 
alter the physiological response to exercise, resulting in a similar time to exhaustion and 




Following exercise of equal duration and intensity, similar levels of end exercise 
quadriceps fatigue were attained with either AOC or PL consumption (Figure 6). M-wave 
characteristics were again preserved from preexercise values, and the %VMA was 
reduced by ~3% in both conditions. The physiological response to exercise was not 




This study has documented the ability of an oral AOC (vitamins C, E and alpha-
lipoic acid) to reduce the resting plasma free radical concentration in patients with 
COPD. A broad array of resting free radical levels, however, were also observed, which 
is in line with the diverse etiology of COPD, which were inversely correlated with FEV1 
as well as baseline MVC force. Indeed, the efficacy of the antioxidant cocktail in this 
population appeared to be affected by the heterogeneity of both the degree of lung 
dysfunction and subsequent free radical load in the current subjects. Therefore, despite 
clearly documented antioxidant effects, we did not observe any functional consequences 
in terms of KE exercise endurance time or end-exercise quadriceps fatigue. Collectively, 
these data suggest that this oral AOC is most efficacious when the oxidant load is 
elevated, and this susceptibility to oxidative stress may be related to pulmonary disease 
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severity, but an acute free-radical reduction does not necessarily impact skeletal muscle 
function in patients with COPD.  
 
Oxidative Stress and Lung Disease 
 
Oxidative stress has been implicated in a variety of pathophysiological roles in the 
etiology of COPD, including modulation of redox sensitive inflammation, mitochondrial 
dysfunction, and alterations in myofilament interactions (17, 25). Indeed, there are 
numerous instances where an elevated oxidant burden has been documented, both 
systemically (15) and in the lung (10, 37), in patients with COPD. Specifically, Barreiro 
et al (10) documented higher protein carbonyl groups, a marker of protein oxidation, in 
diaphragm muscle samples of patients with severe COPD, which were inversely 
correlated with FEV1 across those patients with moderate to severe airflow obstruction. 
Similar negative correlations between other markers of oxidative damage and airflow 
limitation have also been observed in the exhaled breath condensate (37, 38) as well as in 
the blood (40) of patients with COPD. However, EPR spectroscopy is considered to be 
the most sensitive technique for the direct detection of free radicals (9), and although it 
has been employed previously in the bronchoalveolar lavage fluid of patients with COPD 
(41),  the current study is the first to use the technique to directly assay the concentration 
of oxygen- and carbon-centered free radicals in the plasma of patients with COPD, 
reflective of the systemic free radical concentration.  
Resting free radical concentration, across the range of disease severity in this 
study cohort, tended to be inversely correlated with FEV1 (r = -0.54, p = 0.08, Figure 3), 
a finding that is in accord with previous literature, and corroborates the role of oxidative 
stress in the pathology of COPD. The measured resting free radical concentration also 
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tended to be negatively correlated with baseline MVC force (r = -0.54, p = 0.09, Figure 
3), implying a detrimental relationship between pulmonary disease severity, systemic free 
radical load and skeletal muscle function. AOC administration significantly reduced the 
concentration of plasma free radicals, assessed by EPR spectroscopy, consequent to an 
increase in plasma ascorbate levels (Figure 4). However, upon secondary analysis, a 
dichotomous response to the AOC was observed (Figure 8). Indeed, in terms of reducing 
free radicals, the AOC seemed to be most efficacious in those patients with high initial 
levels, with minimal effects in those with the lowest concentrations, despite a universal 
increase in plasma ascorbate. This finding parallels previously documented paradoxical 
effects of the AOC in other populations (45, 54). Thus, the current data support a role for 
the AOC to combat an elevated oxidant burden in patients with COPD, which, perhaps, 
may only be a concern in those patients with significant disease progression.  
 
Performance Time and Oxidative Stress 
 
Evidence exists for a role of oxidative stress in modulating exercise performance 
(43). Germane to the current study, Koechlin et al. (27) documented an improvement in 
quadriceps exercise time to exhaustion following oral NAC administration in patients 
with COPD, which was accompanied by an amelioration of the exercise induced increase 
in plasma TBARs observed in the placebo condition. The effects of NAC, however, are 
not unique to patients with COPD, as beneficial effects have also been documented in 
young, healthy subjects (33, 44), although typically only following intravenous 
administration which can yield greater plasma NAC levels. Such effects on exercise 
performance have not typically been demonstrated with vitamins C, E, or alpha lipoic 
acid (8, 43); however, the current study, to our knowledge, is the first to assess the 
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potential for nonpharmacological doses of these vitamins in modulating exercise 
performance in COPD.  
In contrast to the effects observed with NAC, the AOC did not change exercise 
time to exhaustion or the magnitude of quadriceps fatigue achieved at task failure (Figure 
5). This was despite the striking similarities between the characteristics of the subjects in 
the study by Koechlin et al. (27) and the current study’s cohort (i.e., moderate to severe 
COPD and an average age of 62 yrs of age). This may potentially be explained by the 4-
day loading period employed by the aforementioned study, enhancing the ability for 
NAC to enter the skeletal muscle itself. However, the principal aim of the current study 
was to document the efficacy of an acute, oral AOC with no known side effects, in the 
context of rehabilitative medicine. Thus, in an attempt to reconcile these discordant 
responses, in light of our AOC efficacy data, we correlated the change in free radical 
concentration following AOC consumption with the change in endurance time, but, 
somewhat disappointingly, did not find evidence of a relationship. Therefore, these data 
suggest that acutely decreasing free radicals in patients with COPD with the AOC does 
not translate to improved exercise capacity.  
 
Oxidative Stress and Fatigue 
 
Exercising skeletal muscle has been documented to contribute to the elevated 
oxidant load in COPD (15, 16), which, in turn, has been suggested to contribute to 
limited exercise capacity in this population (17). Indeed, Couillard et al. (16) have 
previously documented an inverse relationship between the exercise-induced increase in 
muscle oxidative stress and quadriceps endurance time in patients with COPD. In the 
current study there was no evidence of a relationship between exercise performance and 
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plasma free radical concentration at any time point. Due to the inherent variability in 
exercise performance trials, we employed isotime exercise to allow comparisons of the 
magnitude of end-exercise fatigue following identical exercise bouts with PL and the 
AOC. As illustrated in Figure 7, the physiological responses to the isotime exercise bouts 
were remarkably similar, at the very least illustrating the potential to achieve 
reproducible physiological measurements in a historically varied population. Pertinent to 
peripheral fatigue development during KE exercise, the percent increase in the iEMG 
signal, an index of central motor drive to the muscle, was one of these nearly identical 
responses assessed in both trials (Figure 7). Accordingly, no differences in end-exercise 
peripheral fatigue were observed (Figure 6), which again were unrelated, by correlational 
analysis, to a change in free radical concentration with AOC consumption. Therefore, 
although the EPR data imply a relationship between chronic oxidative stress and muscle 
function in patients with COPD (Figure 3), acute amelioration of this oxidant load does 
not diminish the magnitude of end-exercise quadriceps fatigue following dynamic KE 
exercise. 
 
Blood Flow, Vascular Function, Oxygen Delivery and Oxidative Stress  
 
The preponderance of efficacy data for this AOC is derived from studies 
examining vascular function in populations predisposed to oxidative stress (21, 45, 53, 
54). Specifically, our group has documented that the AOC can restore vascular function 
in the elderly as assessed by flow-mediated dilation (52) and submaximal handgrip 
exercise (21). In addition, this AOC has been observed to improve end-exercise muscle 
perfusion, evaluated during plantar flexion exercise utilizing nuclear magnetic resonance 
spectroscopy, resulting in an improvement in muscle oxidative capacity (53). Thus, it 
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would be reasonable to assume that in patients with COPD with consistently documented 
elevations in markers of oxidative stress (15, 16, 37), the vascular effects of the AOC 
would be more pronounced. Although evidence for the translation of improved vascular 
function to improved exercising muscle blood flow is relatively sparse, antioxidant driven 
increases in the bioavailability of the vasodilator nitric oxide, secondary to a reduction in 
oxidative stress, may improve skeletal muscle blood flow and potentially oxygen delivery 
(18, 24), which would likely improve exercise performance (1). Thus, in the current 
study, femoral artery blood flow was measured during KE exercise; however, no 
difference between the PL and AOC trials was observed (Figure 7). Collectively, these 
data are suggestive of similar oxygen delivery to the working muscle, although it is 
possible that the initial impact of the varied baseline free radical concentration and the 




This study reveals a negative relationship between COPD severity, skeletal 
muscle function, and resting free radical concentration, as assessed by blood EPR 
measurements, and documents the efficacy of an oral AOC in reducing oxidative stress. 
Importantly, this study also reveals that low free radical levels prior to ingestion of the 
AOC in this population may temper these antioxidant effects. However, a translation to 
improved KE exercise performance is not supported by the current data. Thus, although a 
potentially beneficial role for the AOC can be inferred for patients with COPD, this acute 
reduction in free radicals does not appear to be related to KE exercise endurance or 
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Table 2. Subject characteristics 
 
 
Age (yr)  62 ± 3 
Height (m)  1.73 ± 0.03 
Weight (kg)  84.1 ± 7.4  
BMI (kg/m2)  27.9  ± 1.7 
Quadriceps muscle mass (kg) 1.71  ± 0.2  
Peak knee-extensor work rate (W)   28 ± 3  
Male/Female  7/3 
Pulmonary function   
      Forced vital capacity, l (% predicted) 3.58 ± 0.2 (86.18 ± 4.7) 
      Forced expiratory volume in one s, l/s (% predicted) 1.81 ± 0.2 (57.09 ± 4.6) 
      FEV1/FVC (%) 50.45 ± 4.9 
Resting arterial blood gases (n = 8)  
      Hemoglobin concentration (g/dl) 13.5 ± 0.5 
      Oxyhemoglobin (%) 91.9 ± 0.6 
      Partial pressure of oxygen (mmHg) 69.9 ± 2.0 
      Partial pressure of carbon dioxide (mmHg) 32.2 ± 2.0 
      Bicarbonate (mmol/l) 22.0 ± 1.4 
      pH 7.45 ± 0.01 
Values expressed as mean ± S.E.M. FEV1/FVC = Forced expiratory volume in one 













Figure 3. Relationships between forced expiratory volume in 1 second (FEV1) and 
quadriceps maximal voluntary contraction (MVC) with resting free radical 
concentration assessed by electron paramagnetic resonance (EPR) spectroscopy. 
Resting free radical concentration (AUC, arbitrary units) tended to be moderately 
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Figure 4. Resting antioxidant and oxidant status assayed in the plasma following 
placebo (PL) and antioxidant cocktail (AOC) consumption. Data are presented as 
mean ± S.E.M. AOC consumption resulted in an increase in plasma ascorbic acid (A) and 
a reduction in the free radical concentration assessed by electron paramagnetic resonance 
(EPR) spectroscopy area under the curve (AUC, arbitrary units) (B). *Significantly 

















Figure 5. Endurance time and end-exercise quadriceps fatigue assessed following 
exhaustive knee extensor exercise with either the consumption of a placebo (PL) or 
an antioxidant cocktail (AOC). Data are presented as mean ± S.E.M. Quadriceps 
fatigue values represent the percent change from pre- to post-exercise. Qtw,pot, potentiated 







Figure 6. End-exercise quadriceps fatigue assessed following constant workload 
knee extensor exercise matched for intensity and duration (isotime) following 
consumption of either placebo (PL) or antioxidant cocktail (AOC) Data are presented 
as mean ± S.E.M and values represent the percent change from pre- to post-exercise. 
Qtw,pot, potentiated twitch force; MVC, maximal voluntary contraction. There were no 












Figure 7. Physiological responses to constant workload knee extensor exercise 
matched for intensity and duration (isotime) following consumption of either a 
placebo (PL) or an antioxidant cocktail (AOC). Data are presented as mean ± S.E.M. 
End exercise values for femoral blood flow are not reported due to loss of signal. VE, 
ventilation; VO2, oxygen consumption; VCO2, carbon dioxide production; iEMG, 
integrated electromyogram. There were no statistically significant differences between 
























































































Figure 8. Individual changes in the α-Phenyl-tert-butylnitrone (PBN) spin adduct 
area under the curve (AUC, arbitrary unit) assessed by electron paramagnetic 
resonance (EPR) spectroscopy following the ingestion of both the placebo (PL) and 
antioxidant cocktail (AOC). Individual responses have been separated into two groups, 
those with low (left) and higher (right) initial values in the PL condition. As illustrated, 
the AOC appeared to only have an effect in those with high initial levels of oxidative 
stress, which is evidence that the baseline free radical load impacts the effect of the AOC. 
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Elucidating the mechanisms contributing to skeletal muscle fatigue in health and 
disease is important both scientifically and in terms of rehabilitative medicine, which 
may enhance the quality of life in populations with limited mobility. Among these 
mechanisms, group III and IV afferent feedback from exercising muscle, which relays 
information regarding metabolic disturbance and the magnitude of peripheral fatigue, has 
been documented to substantially influence the voluntary termination of endurance 
exercise performance (1), and therefore, is highly germane to the study of exercise 
intolerance. Active muscle mass and oxidative stress have both been documented to alter 
skeletal muscle afferent activity (4, 5), and thus the manipulation of these two factors has 
the potential to alter exercise capacity. In addition, an excessive free radical load has been 
recognized to depress contractile function (2) and therefore accelerate the development of 
peripheral fatigue. Accordingly, first, endurance exercise performance as well as the 
magnitude of end-exercise quadriceps fatigue was examined in a healthy, young group of 
subjects to determine the effect of varying the amount of active muscle mass on muscle 
fatigue. Second, the effect of an oral AOC, with previously documented efficacy in 
attenuating free radicals (8, 9), on skeletal muscle fatigue was studied in a population 
with a heightened susceptibility to oxidative stress and well-documented exercise 
intolerance, patients with COPD.  
 In the first study, we sought to vary the volume of muscle mass active during 
dynamic constant workload, single-leg KE and BIKE exercise, to alter the ensemble 
magnitude of group III/IV afferent feedback (5), and examine the impact on end-exercise 
peripheral quadriceps fatigue in young, healthy subjects. With this approach, we observed 
far greater quadriceps compared to BIKE fatigue following KE exercise to exhaustion. 
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This effect was likely due to the constraint of muscle afferent feedback to the one 
quadriceps muscle during KE exercise such that, at task failure, the critical level of 
ensemble afferent feedback influencing the voluntary termination of exercise was 
eventually reached by a strong, local afferent signal in contrast to the sum of the more 
diffuse signals during BIKE exercise. Thus, the magnitude of peripheral fatigue in the 
quadriceps muscle, presumably necessary to elicit the strong local afferent signal, was 
greater following KE exercise. These data suggest that the CNS tolerates a greater degree 
of peripheral fatigue during small muscle mass exercise, and have important implications 
for rehabilitative medicine. Specifically, small muscle mass training appears to facilitate 
a greater local homeostatic disturbance and therefore may promote greater muscle 
adaptation. 
 The second study examined the impact of an oral AOC on free radical 
concentration, dynamic KE exercise performance, and peripheral quadriceps fatigue in 
patients with COPD. In this population with consistently documented elevations in 
oxidative stress (3, 6, 7), we observed a tendency for an inverse relationship between 
resting free radical concentration and airflow limitation, assessed by FEV1, as well as 
baseline MVC force. The efficacy of the AOC, however, was dependent upon initial 
levels of free radicals, significantly decreasing free radicals in those with high initial 
levels, but having little effect in those patients with low baseline levels. Despite these 
antioxidant effects, no differences in endurance exercise performance or the magnitude of 
peripheral quadriceps fatigue were observed following AOC ingestion. Collectively, 
these data document the efficacy of the AOC to acutely reduce resting free radicals in 
patients with COPD, which may only be a concern in those patients with significant 
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disease progression. However, despite the suggestion of a relationship between chronic 
oxidative stress and skeletal muscle dysfunction in the study cohort, acutely reducing the 
free radical concentration with the AOC in patients with COPD does not necessarily 
impact skeletal muscle function during dynamic KE exercise.  
  In summary, the study of skeletal muscle fatigue is certainly of importance in the 
context of rehabilitative medicine, which is highly germane in populations with limited 
exercise capacity, such as patients with COPD. These studies have provided novel insight 
into the use of small muscle mass exercise to enable the attainment of a greater degree of 
peripheral quadriceps fatigue, potentially eliciting greater skeletal muscle adaptation. In 
addition, despite failing to document an effect of an AOC on peripheral fatigue in COPD, 
the second study has further substantiated the role of oxidative stress in the pathology of 
this lung disease and identified a beneficial antioxidant effect, most notably in those 
patients with more severe airflow obstruction. Further investigations addressing the role 
of free radicals and fatigue in patients with COPD, perhaps in patients with more 
homogeneously elevated levels of oxidative stress and perhaps with greater 
concentrations of antioxidants, are needed. However, the conclusions garnered from the 
current studies still have broad implications for improving rehabilitative medicine, and 
thus quality of life, in both health and disease, and have contributed to a better 
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